Rbf Capital, LLC Surface Oncology, Inc. Transaction History

Rbf Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 18, 2020	SELL	$1.44 - $3.95 $66,553 - $182,561	-46,218 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$1.17 - $2.33 $64,575 - $128,599	-55,193 Reduced 54.43%	46,218 $88,000
Q3 2019 Nov 13, 2019	BUY	$1.4 - $2.84 $141,975 - $288,007	101,411 New	101,411 $144,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Rbf Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Rbf Capital, LLC with notifications on news.